IRIS

1.5 Abstract in rivista: [2184] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 521 a 540 di 2.184
Titolo Data di pubblicazione Autore(i) File
CLINICAL RELEVANCE OF BASELINE/EARLY DETECTION AND PERSISTENCE OF RESISTANT ASSOCIATED VARIANTS IN HCV-1 PATIENTS TREATED WITH PROTEASE-INHIBITORS ASSESSED BY ULTRA-DEEP SEQUENCING 1-gen-2015 Di Maio, Vc; Armenia, D; Bellocchi, Mc; Di Paolo, D; Cento, V; Tontodonati, M; Micheli, V; Carioti, L; De Leonardis, F; Aragri, M; Polilli, E; Manunta, A; Magni, C; Antonucci, Fp; De Luca, F; Sarrecchia, C; Bertoli, A; Lenci, I; Francioso, S; Santoro, Mm; Vecchiet, J; De Maria, A; Picciotto, A; Nosotti, L; Morisco, F; Bruno, S; Puoti, M; Babudieri, S; Mura, Ms; Taliani, G; Andreoni, M; Rizzardini, G; Parruti, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
DIFFERENT PREVALENCE OF HCV RESISTANCE AND HCV QUANTIFICATION WITHIN BLOOD AND LIVER SAMPLES (TUMORAL AND NON TUMORAL TISSUES) OF HCC/TRANSPLANTED PATIENTS 1-gen-2016 Sorbo, Mc; Antonucci, Fp; Manuelli, M; Lenci, I; Sforza, D; Carioti, L; Bellocchi, Mc; Cento, V; Di Paolo, D; De Leonardis, F; Milana, M; Manzia, T; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
ROLE OF CIRCULATING SURVIVIN-IGM IMMUNOCOMPLEXES IN PATIENTS AFFECTED BY LIVER DISEASES 1-gen-2010 Sorrentino, R; Ettorre, Gm; Bellis, L; Antenucci, A; Santoro, R; Vennarecci, G; Svicher, V; Cento, V; Beneduce, L; Biasiolo, A; Pontisso, P; Puoti, C; Pierimarchi, P; Garaci, E; Rasi, G; Matteucci, C
SLOW ACHIEVEMENT OF HCV-RNA UNDETECTABILITY IN CIRRHOTIC PATIENTS TREATED WITH SOFOSBUVIR plus RIBAVIRIN: POSSIBLE CLINICAL IMPLICATIONS IN THE LIVER TRANSPLANT LIST MANAGEMENT 1-gen-2015 Lenci, I; Cento, V; Rendina, M; Donato, Mf; Milana, M; Sforza, D; Manuelli, M; Aragri, M; Di Maio, Vc; Abedrabbo, A; Castellaneta, A; Malinverno, F; Monico, S; Ponti, Ml; Canu, R; Ganga, R; Alfieri, R; Milanesi, L; Di Leo, A; Tisone, G; Perno, Cf; Ceccherini-Silberstein, F; Colombo, M; Angelico, M
HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life 1-gen-2017 Cento, V; Barbaliscia, S; Lenci, I; Ruggiero, T; Masetti, C; Magni, Cf; Micheli, V; Paolucci, S; Troshina, Y; Biliotti, E; Milana, M; Melis, M; Teti, E; Lambiase, L; Menzaghi, B; Nicolini, La; Marenco, S; Di Maio, Vc; Aragri, M; Pecchioli, A; Bertoli, A; Antonucci, Fp; Sarmati, L; Sarrecchia, C; Macera, M; Coppola, N; Danieli, E; Romagnoli, D; Pellicelli, A; Bonora, S; Babudieri, S; Di Biagio, A; Picciotto, A; Novati, S; Siciliano, M; Messina, V; Claar, E; Baldanti, F; Pasquazzi, C; Ciancio, A; Puoti, M; Ghisetti, V; Andreoni, M; Taliani, G; Rizzardini, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
VIROLOGICAL FAILURES TO NEW DIRECT ACTING ANTIVIRALS IN A REAL LIFE SETTING MAY REQUIRE UNCONVENTIONAL REGIMENS FOR RE-TREATMENT 1-gen-2016 Di Maio, Vc; Cento, V; Di Paolo, D; Lenci, I; Aragri, M; Verucchi, G; Melis, M; Bertoli, A; Antonucci, Fp; Francioso, S; Pellicelli, A; Calvaruso, V; Pasquazzi, C; Romagnoli, D; Biolato, M; Vecchiet, J; Morisco, F; Merli, M; Gaeta, Gb; Brillanti, S; Donato, F; Puoti, M; Pisani, V; Paoloni, M; Babudieri, S; Craxi, A; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
Selection and coevolution of mutational patterns in the HIV-1 integrase characterized by pyrosequencing analysis 1-gen-2009 Ceccherini-Silberstein, F; Armenia, D; D'Arrigo, R; Vandenbroucke, I; Van Marck, H; Fabeni, L; Cento, V; Van Baelen, K; Rizzardini, G; Lo Caputo, S; Tozzi, V; Narciso, P; Antinori, A; Stuyver, L; Perno, Cf
THE GENOTYPIC FALSE POSITIVE RATE DETERMINED BY POPULATION V3-SEQUENCING CAN PREDICT THE BURDEN OF X4 QUASISPECIES DETECTED BY PYROSEQUENCING 1-gen-2011 Cento, V; Svicher, V; Rozera, G; Abbate, I; Santoro, Mm; Armenia, D; Fabeni, L; Palamara, G; Latini, A; Rizzardini, G; Micheli, V; Buonomini, Ar; Andreoni, M; Perno, Cf; Capobianchi, Mr; Ceccherini-Silberstein, F
EARLY-PHASE HCV KINETICS AND ROLE OF PRE-EXISTING RESISTANCE IN CIRRHOTIC OR INTERFERON-INSENSITIVE PATIENTS ON DACLATASVIR PLUS ASUNAPREVIR 1-gen-2015 Cento, V; Calvaruso, V; Marenco, S; Alfieri, R; Aragri, M; Antonucci, Fp; Di Maio, Vc; Petta, S; Mazzola, A; Milanesi, L; Picciotto, A; Ceccherini-Silberstein, F; Craxi, A; Perno, Cf
DIFFERENT PREVALENCE OF HCV RESISTANCE AND HCV RNA QUANTIFICATION WITHIN TUMORAL AND NON TUMORAL LIVER TISSUES IN HCC/TRANSPLANTED PATIENTS 1-gen-2016 Sorbo, Mc; Antonucci, Fp; Manuelli, M; Lenci, I; Sforza, D; Carioti, L; Bellocchi, Mc; Cento, V; Di Paolo, D; De Leonardis, F; Milana, M; Manzia, T; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
HCV GENOTYPES HAVE DIFFERENT GENETIC BARRIERS IN THE GENERATION OF RESISTANCE MUTATIONS TO PROTEASE INHIBITORS IN ADVANCED CLINICAL DEVELOPMENT 1-gen-2011 Cento, V; Mirabelli, C; Mercurio, F; Salpini, R; Dimonte, S; Svicher, V; Bertoli, A; Ciotti, M; Almerighi, C; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
BASELINE/EARLY PRESENCE OF KNOWN AND NOVEL RESISTANCE MUTATIONS IS ASSOCIATED WITH VIRAL FAILURE IN DIFFICULT-TO-TREAT PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORS 1-gen-2014 Cento, V; Di Maio, Vc; Di Paolo, D; Micheli, V; Tontodonati, M; De Leonardis, F; Aragri, M; Antonucci, Fp; Mancon, A; Armenia, D; Bellocchi, Mc; Lenci, I; Manunta, A; Taliani, G; Di Biagio, A; Nicolini, La; Nosotti, L; Sarrecchia, C; Siciliano, M; Landonio, S; Pellicelli, A; Gasbarrini, A; Vecchiet, J; Magni, Cf; Babudieri, S; Mura, Ms; Andreoni, M; Parruti, G; Rizzardini, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
Prevalence and characteristics of resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy 1-gen-2017 Di Maio, Vc; Barbaliscia, S; Lenci, I; Teti, E; Antonucci, Fp; Cento, V; Aragri, M; Paolucci, S; Bruzzone, B; Coppola, N; Ruggiero, T; Pollicino, T; Polilli, E; Pasquazzi, C; Palitti, Vp; Magni, Cf; Micheli, V; Di Biagio, A; Sticchi, L; Melis, M; Francioso, S; Masetti, C; Foroghi, L; Sarrecchia, C; Baiocchi, L; Landonio, S; Bertoli, A; Calvaruso, V; Morisco, F; Maida, I; Marenco, S; Leo, A; Ghisetti, V; Ciancio, A; Sacchi, P; Novati, S; Brancaccio, G; Pieri, A; Puoti, M; Toniutto, P; Vullo, V; Aghemo, A; Di Perri, G; Babudieri, S; Rizzardini, G; Bruno, S; Pellicelli, A; Taliani, G; Raimondo, G; Baldanti, F; Gaeta, Gb; Craxi, A; Parruti, G; Andreoni, M; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
Multiclass hepatitis C virus resistance to direct acting antivirals in real life interferon-free regimens failures advocates for tailored second-line therapies 1-gen-2017 Di Maio, Vc; Cento, V; Lenci, I; Aragri, M; Barbaliscia, S; Francioso, S; Paolucci, S; Melis, M; Verucchi, G; Coppola, N; Magni, Cf; Micheli, V; Pollicino, T; Ruggiero, T; Santopaolo, F; Landonio, S; Mancon, A; Starace, M; Bertoli, A; Antonucci, Fp; D'Ambrosio, C; Calvaruso, V; Morisco, F; Pasquazzi, C; Maida, I; Picciotto, A; Biagio, Ad; Bruzzone, B; Sticchi, L; Ghisetti, V; Cozzolongo, R; Romagnoli, D; Boccaccio, V; Grieco, A; Vecchiet, J; D'Ettorre, G; Merli, M; Gaeta, Gb; Ciancio, A; Marinaro, L; Andreone, P; Barbarini, G; Gulminetti, R; Palitti, Vp; Tarquini, P; Puoti, M; Sangiovanni, V; Stefano, Gd; Giorgini, A; Paoloni, M; Caporaso, N; Babudieri, S; Gubertini, G; Bruno, S; Andreoni, M; Pellicelli, A; Parruti, G; Raimondo, G; Baldanti, F; Craxi, A; Angelico, M; Perno, F; Ceccherini-Silberstein, F
Virological failures to direct acting antivirals (DAA) regimens in a real life setting show frequent resistance associated variants and may require re-treatment with unconventional strategies 1-gen-2016 Di Maio, Vc; Cento, V; Lenci, I; Aragri, M; Barbaliscia, S; Francioso, S; Paolucci, S; Melis, M; Verucchi, G; Coppola, N; Magni, Cf; Santopaolo, F; Landonio, S; Ghisetti, V; Starace, M; D'Ambrosio, C; Calvaruso, V; Caporasol, N; Pasquazzi, C; Maida, I; Picciotto, A; Di Biagio, A; Sticchi, L; Cozzolongo, R; Romagnoli, D; Biolato, M; Vecchiet, J; D'Ettorre, G; Merli, M; Gaeta, Gb; Ciancio, A; Marinaro, L; Andreone, P; Barbarini, G; Gulminetti, R; Palitti, Vp; Tarquini, P; Puoti, M; Sangiovanni, V; Paoloni, M; Babudieri, S; Rizzardini, G; Bruno, S; Andreoni, M; Pellicelli, Am; Parruti, G; Craxi, A; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
THE GENETIC BARRIER MODULATES THE IMMUNE ESCAPE POTENTIAL OF HBV GENOTYPES 1-gen-2010 Svicher, V; Cento, V; Salpini, R; Merucurio, F; Han, Y; Gori, C; Wittkop, L; Fraune, M; Bertoli, A; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, N; Mazzotte, F; De Sanctis, Gm; Verheyen, J; Trimoulet, P; Angelico, M; Zhang, Xx; Ceccherini-Silberstein, F; Perno, Cf
HCV DIVERSITY AND FIBROSIS PROGRESSION: NS5A AND CORE VARIANTS CORRELATE WITH SEVERITY OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION 1-gen-2013 Lenci, I; Cucchiarelli, S; Di Maio, Vc; Cento, V; De Luca, F; Milana, M; Antonucci, Fp; Di Paolo, D; Giardina, E; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
Key genetic markers in the full-length HBsAg gene correlate with HBV-driven carcinogenesis by affecting HBsAg secretion and release 1-gen-2013 Svicher, V; Neumann-Fraune, M; Mirabelli, C; Salpini, R; Cento, V; Di Maio, Vc; Bertoli, A; Alteri, C; Aragri, M; Gori, C; Micheli, V; Salso, A; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrecchia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Verhejen, J; Perno, Cf
Natural HCV resistance is common in Italy and differently associated to genotypes 1-gen-2017 Sorbo, Mc; Cento, V; Bertoli, A; Lenci, I; Polilli, E; Masetti, C; Gianserra, L; Teti, E; Biliotti, E; Magni, Cf; Aragri, M; Micheli, V; Melis, M; Nicolini, La; Marenco, S; Calvaruso, V; Paolucci, S; Baldanti, F; Morisco, F; Siciliano, M; Palitti, Vp; Andreone, P; Bruzzone, B; Coppola, N; Ruggiero, T; Lichtner, M; Menzaghi, B; Romagnoli, D; Iapadre, N; Di Maio, Vc; De Leonardis, F; Milana, M; Cacciatore, P; Pieri, A; Sarmati, L; Landonio, S; Gasbarrini, A; Puoti, M; Craxi, A; Vullo, V; Pellicelli, A; Babudieri, S; Rizzardini, G; Taliani, G; Andreoni, M; Pasquazzi, C; Parruti, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
CLINICAL RELEVANCE OF ACCURATE HCV GENOTYPE AND SUBTYPE ASSIGNMENT BY NS3/NS5A/NS5B DIRECT SEQUENCING IN THE ERA OF NEW DIRECT ACTING ANTIVIRAL AGENTS 1-gen-2016 Aragri, M; Di Maio, Vc; Di Paolo, D; Cento, V; De Leonardis, F; Gianserra, L; Tontodonati, M; Micheli, V; Landonio, S; Manunta, A; Bertoli, A; Ciotti, M; Antonucci, Fp; Campoli, R; La Rosa, Ky; Deodati, F; Lenci, I; Francioso, S; Nicolini, La; Marenco, S; Teti, E; Lambiase, L; Milana, M; Maida, I; Di Biagio, A; Pellicelli, A; Nosotti, L; Grieco, S; Cacciatore, P; Romagnoli, D; Siciliano, M; D'Ettorre, G; Babudieri, S; Lichtner, M; Vespasiani-Gentilucci, U; Romano, M; Sarrecchia, C; Grieco, A; Morisco, F; Mastroianni, C; Vecchiet, J; Puoti, M; D'Amico, E; Caporaso, N; Gasbarrini, A; Bruno, S; Magni, C; Mura, Ms; Taliani, G; Picciotto, A; Rizzardini, G; Andreoni, M; Pasquazzi, C; Parruti, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 521 a 540 di 2.184
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista2184
Autore
  • Oyen, Willem Jozef Gerard230
  • GUAZZONI, GIORGIO FERRUCCIO161
  • Scorsetti, Marta128
  • Repici, Alessandro126
  • Armuzzi, Alessandro105
  • Lughezzani, Giovanni104
  • SANTORO, Armando87
  • CHITI, ARTURO86
  • Buffi, Nicolomaria85
  • Mangiavillano, Benedetto83
Data di pubblicazione
  • 2020 - 2026115
  • 2010 - 20191351
  • 2000 - 2009606
  • 1990 - 1999111
  • 1988 - 19891
Editore
  • Nature Publishing Group4
  • s.n4
  • ICRS3
  • Blackwell1
Rivista
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...124
  • EUROPEAN UROLOGY. SUPPLEMENTS124
  • GASTROENTEROLOGY123
  • THE JOURNAL OF UROLOGY111
  • DIGESTIVE AND LIVER DISEASE100
  • THE JOURNAL OF NUCLEAR MEDICINE80
  • ANNALS OF THE RHEUMATIC DISEASES69
  • RADIOTHERAPY AND ONCOLOGY59
  • ANNALS OF ONCOLOGY57
  • JOURNAL OF CLINICAL ONCOLOGY45
Keyword
  • Myelodysplastic syndrome8
  • Survival4
  • biomimetic3
  • Mitochondrial ferritin3
  • osteochondral3
  • Prognosis3
  • scaffold3
  • Sideroblastic anemia3
  • viscosupplementation3
  • COLONOSCOPIC SURVEILLANCE2
Lingua
  • eng817
  • ita28
  • und6
Accesso al fulltext
  • no fulltext2131
  • reserved51
  • open2